Zydus Lifesciences is currently trading at Rs. 1005.00, up by 43.25 points or 4.50% from its previous closing of Rs. 961.75 on the BSE.
The scrip opened at Rs. 973.65 and has touched a high and low of Rs. 1011.90 and Rs. 969.65 respectively. So far 308877 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1323.90 on 09-Aug-2024 and a 52 week low of Rs. 685.85 on 18-Jan-2024.
Last one week high and low of the scrip stood at Rs. 1011.90 and Rs. 954.65 respectively. The current market cap of the company is Rs. 101116.45 crore.
The promoters holding in the company stood at 74.98%, while Institutions and Non-Institutions held 18.17% and 6.85% respectively.
Zydus Lifesciences has entered into an agreement with CVS Caremark, a CVS Health company to add Zituvio, Zituvimet and Zituvimet XR (Sitagliptin / Sitagliptin and Metformin Hydrochloride) tablets to its template formulary. CVS Caremark will add the company’s Zituvio and combination products to its template formulary starting January 1, 2025.
Zituvio and combination products include Zituvio (sitagliptin), Zituvimet (sitagliptin and metformin hydrochloride) and Zituvimet XR (sitagliptin and metformin hydrochloride) extended-release tablets. These three NDAs of Sitagliptin (base) and combination franchise have been approved by the United States Food and Drug Administration (USFDA) earlier through the 505(b)(2) route. The Zituvio range of products contain active ingredients sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
According to IQVIA (MAT August-2023), U.S. market for DPP-IV inhibitors and their combinations is $10 billion.
Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1643.05 |
Dr. Reddys Lab | 1151.95 |
Cipla | 1474.30 |
Lupin | 1906.15 |
Zydus Lifesciences | 885.10 |
View more.. |